Waszkowycz B - Search Results

1

PRO-LIGAND: an approach to de novo molecular design. 1. Application to the design of organic molecules.

Clark DE, Frenkel D, Levy SA, Li J, Murray CW, Robson B, Waszkowycz B, Westhead DR. Clark DE, et al. Among authors: waszkowycz b. J Comput Aided Mol Des. 1995 Feb;9(1):13-32. doi: 10.1007/BF00117275. J Comput Aided Mol Des. 1995. PMID: 7751867

2

PRO_LIGAND: an approach to de novo molecular design. 4. Application to the design of peptides.

Frenkel D, Clark DE, Li J, Murray CW, RObson B, Waszkowycz B, Westhead DR. Frenkel D, et al. Among authors: waszkowycz b. J Comput Aided Mol Des. 1995 Jun;9(3):213-25. doi: 10.1007/BF00124453. J Comput Aided Mol Des. 1995. PMID: 7561974

3

PRO-LIGAND: an approach to de novo molecular design. 3. A genetic algorithm for structure refinement.

Westhead DR, Clark DE, Frenkel D, Li J, Murray CW, Robson B, Waszkowycz B. Westhead DR, et al. Among authors: waszkowycz b. J Comput Aided Mol Des. 1995 Apr;9(2):139-48. doi: 10.1007/BF00124404. J Comput Aided Mol Des. 1995. PMID: 7608745

4

PRO_LIGAND: an approach to de novo molecular design. 2. Design of novel molecules from molecular field analysis (MFA) models and pharmacophores.

Waszkowycz B, Clark DE, Frenkel D, Li J, Murray CW, Robson B, Westhead DR. Waszkowycz B, et al. J Med Chem. 1994 Nov 11;37(23):3994-4002. doi: 10.1021/jm00049a019. J Med Chem. 1994. PMID: 7966160

5

PRO_SELECT: combining structure-based drug design and combinatorial chemistry for rapid lead discovery. 1. Technology.

Murray CW, Clark DE, Auton TR, Firth MA, Li J, Sykes RA, Waszkowycz B, Westhead DR, Young SC. Murray CW, et al. Among authors: waszkowycz b. J Comput Aided Mol Des. 1997 Mar;11(2):193-207. doi: 10.1023/a:1008094712424. J Comput Aided Mol Des. 1997. PMID: 9089436

6

New approach to molecular docking and its application to virtual screening of chemical databases.

Baxter CA, Murray CW, Waszkowycz B, Li J, Sykes RA, Bone RG, Perkins TD, Wylie W. Baxter CA, et al. Among authors: waszkowycz b. J Chem Inf Comput Sci. 2000 Mar;40(2):254-62. doi: 10.1021/ci990440d. J Chem Inf Comput Sci. 2000. PMID: 10761126

7

The design of phenylglycine containing benzamidine carboxamides as potent and selective inhibitors of factor Xa.

Jones SD, Liebeschuetz JW, Morgan PJ, Murray CW, Rimmer AD, Roscoe JM, Waszkowycz B, Welsh PM, Wylie WA, Young SC, Martin H, Mahler J, Brady L, Wilkinson K. Jones SD, et al. Among authors: waszkowycz b. Bioorg Med Chem Lett. 2001 Mar 12;11(5):733-6. doi: 10.1016/s0960-894x(01)00042-7. Bioorg Med Chem Lett. 2001. PMID: 11266180

8

PRO_SELECT: combining structure-based drug design and array-based chemistry for rapid lead discovery. 2. The development of a series of highly potent and selective factor Xa inhibitors.

Liebeschuetz JW, Jones SD, Morgan PJ, Murray CW, Rimmer AD, Roscoe JM, Waszkowycz B, Welsh PM, Wylie WA, Young SC, Martin H, Mahler J, Brady L, Wilkinson K. Liebeschuetz JW, et al. Among authors: waszkowycz b. J Med Chem. 2002 Mar 14;45(6):1221-32. doi: 10.1021/jm010944e. J Med Chem. 2002. PMID: 11881991

9

Application of virtual screening to the discovery of novel nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with potential for the treatment of cancer and axonopathies.

Clark DE, Waszkowycz B, Wong M, Lockey PM, Adalbert R, Gilley J, Clark J, Coleman MP. Clark DE, et al. Among authors: waszkowycz b. Bioorg Med Chem Lett. 2016 Jun 15;26(12):2920-2926. doi: 10.1016/j.bmcl.2016.04.039. Epub 2016 Apr 16. Bioorg Med Chem Lett. 2016. PMID: 27158141 Free article.

10

Structure-based approaches to drug design and virtual screening.

Waszkowycz B. Waszkowycz B. Curr Opin Drug Discov Devel. 2002 May;5(3):407-13. Curr Opin Drug Discov Devel. 2002. PMID: 12058616 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page